Chemcial, Pharmaceutical intermediate, Veterinary drug intermediates, Pesticide intermediate, New material intermediate

/ABOUT US

CREATING VALUE FOR
THE ENTERPRISE!

We are Zhejiang Multinpharma Co., Ltd. and Brother Company named of Hangzhou Multinpharma.com Co.,Ltd and Hongrui TechaCo., Ltd. and .,were established in February and September 2002, respectively. The pilot plant is located in Zhejiang Toumang Economic Development Zone, Linhai City, Taizhou City, Zhejiang Province. Within the committee), R & D and sales deparment are located in Hangzhou.

Both company are science and technology company focusing on scientific research technology, dedicated to pharmaceutical and chemical production technology services, CRO customization, continuous flow microreaction technology services, and providing overall solutions for microreaction equipment... READ MORE >

OUR PRODUCTS

We have successfully developed more than 150 pharmaceutical intermediate projects, have more than twenty core personnels in the research and development team, and more than half of its graduate degrees! More products please visit our Products on website!

7*24 Hours Service

This area can be fully edited and gives you the opportunity to introduce yourself, your website, your products or your services.

Davis

This area can be customized to add text, the length of the text is customized, does not affect the operation of the entire site.
Rodeny

Have an excellent after-sales service team to ensure that the first time to solve customer after-sales problems.
Dane

We have an excellent technical team, which can be designed according to customers requirements.
Lena

More than 10 precision production line, easy to realize large quantities of goods, to provide you with the best price.

We provide essential maintenance to all customers!

REQUEST A QUOTE

THE ADVANTAGES

We have successfully developed more than 30 pharmaceutical intermediate projects, have more than ten core personnels in the research and development team, and more than half of its graduate degrees!

Engineering Advantages

Inherent engineering advantages such as high-speed mixing, highly efficient heat transfer, controllable reaction residence time, repeatability, and lack of amplification effect often lead to improved process performance.

Fewer Chemicals

Often needs fewer chemicals, and can sometimes be applied to reactions that cannot be run safely in batch mode.

Automated Control

For multi-ton processes, smaller floor coverage and less up-front investment than intermittent batch reaction, and can easily be automated control. This is of great significance for large-scale production.

Chemtrix MR555 microchannel reaction imported equipment is assembled
November 16, 2020

Chemtrix MR555 microchannel reaction imported equipment is assembled Date: 16-11-2020After three years of preparatio

2020 flow chemistry technology seminar held in Shenzhen
November 16, 2020

I am honored to be invited to participate as CEO of Zhejiang Multinpharam Co.,Ltd in the 2020 flow chemistry technology seminar held in Shenzhen, I am also honored to communicate with 8 academicians attended, and 14 experts jointly proposed "Accelerating Basic Research on Flow

Pharmaceutical Process Development: Opportunities and Challenges in Patheon
March 13, 2018

On March 13, at Patheon's Linz Plant (formerly DSM) in Austria, Cheng Dang, a researcher from Fudan University, gave a "Pharmaceutical Process Development: Opportunities and Challenges" report to Patheon's R & D technical team, which was highly praised by Patheon's R & D technical team , Causing a l

Pharmaceutical Process Development: Opportunities and Challenges in Patheon
January 28, 2020

FREE QUOTE

Do you need help with electrical maintenance?
Fill out this form to get in touch.

Engineering Advantages

Fewer Chemicals

Automated Control

Chemtrix MR555 microchannel reaction imported equipment is assembled November 16, 2020

2020 flow chemistry technology seminar held in Shenzhen November 16, 2020

Pharmaceutical Process Development: Opportunities and Challenges in Patheon March 13, 2018